Results 101 to 110 of about 36,882 (280)

The Making of Forum Ware: A High‐Resolution Archaeometric Study of Early Medieval Glazed Pottery From the Templum Pacis (Imperial Forum, Rome)

open access: yesArchaeometry, EarlyView.
ABSTRACT The object of this study consists of an archaeometric investigation of Early medieval Forum Ware glazed ceramics found in the central archaeological area of Rome, a significant chronological and economic marker for 8th–11th centuries. Instrumental analysis included digital microscopy, ESEM‐EDS imaging, EDS spectral analysis, EMPA quantitative ...
Martina Bernardi   +2 more
wiley   +1 more source

Gla

open access: yes, 1982
Touchais Gilles. Gla. In: Bulletin de correspondance hellénique. Volume 106, livraison 2, 1982. pp.
Touchais, Gilles
core  

BrECADD in three days: Implementation of a condensed intensive first‐line regimen in Hodgkin lymphoma

open access: yesBritish Journal of Haematology, EarlyView.
BrECADD can be delivered over 3 days instead of four, reducing intravenous treatment days by 25% without compromising dose intensity. Among 30 patients with advanced‐stage Hodgkin lymphoma, no unexpected toxicity was observed; there were no early discontinuations, and 1‐year progression‐free and overall survival were both 100%.
Christian Peter Jaworek   +16 more
wiley   +1 more source

The National Allergy Centre of Excellence–Addressing Australia's Allergy Burden

open access: yesClinical &Experimental Allergy, EarlyView.
Australia's high allergy burden prompted a national response, leading to the establishment of the National Allergy Centre of Excellence (NACE) in 2022. The NACE has advanced research infrastructure, collaboration, and consumer‐centred care through four pillars, achieving global recognition and accelerating translation into policy, practice, and ...
A. Young   +23 more
wiley   +1 more source

Identification of Copy Number Variants as a Suspected Cause of Cerebral Small Vessel Disease

open access: yesClinical Genetics, EarlyView.
Whole‐exome sequencing of 111 patients with suspected familial cerebral small vessel disease (CSVD) identified novel copy number variants in four patients across NOTCH3, LMNB1, and COL4A2, using bioinformatic and molecular techniques. These validated CNVs suggest structural variation is an underrecognized potential causal contributor to monogenic CSVD ...
Solomon K. Guyler   +5 more
wiley   +1 more source

GLA Members

open access: yes, 2017
This image shows Ruth Esbjornson, John Esbjornson, Carol Esbjornson, Bob Esbjornson, Jean Horman Lanbsjoen at a GLA ...
Telander, C. Lorraine;
core   +1 more source

Beauty in the Eye of AI: Aligning LLMs and Vision Models with Human Aesthetics in Network Visualization

open access: yesComputer Graphics Forum, EarlyView.
Abstract Network visualization has traditionally relied on heuristic metrics, such as stress, under the assumption that optimizing them leads to aesthetic and informative layouts. However, no single metric consistently produces the most effective results.
X. Li, P. Zhang, X. Wang, H. Shen, Y. Hu
wiley   +1 more source

SGLT2 Inhibitors and Cardiovascular Outcomes in Patients With Fabry Disease: Observations From a Federated Research Network

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background and Aim Fabry disease (FD) is frequently complicated by renal impairment and cardiovascular events; however, evidence on sodium–glucose cotransporter‐2 inhibitors (SGLT2i) in this population is scarce. Accordingly, we assessed the association between SGLT2i exposure and cardiovascular outcomes in adults with FD. Methods We conducted
Leandra Serio   +8 more
wiley   +1 more source

High efficiency reduction of 4-nitrophenol on greenly synthesized gold nanoparticles decorated on chitosan matrix (CS-GLA/AuNPs)

open access: yesScientific Reports
An inexpensive bioinspired green approach using Saussurea costus root extract was developed to fabricate CS-GLA/AuNP catalyst for the reduction of 4-nitrophenol (4-NP) to 4-aminophenol (4-AP).
Amel Taha, Norah Alsadun
doaj   +1 more source

Home - About - Disclaimer - Privacy